13.93
전일 마감가:
$12.83
열려 있는:
$12.83
하루 거래량:
381.21K
Relative Volume:
1.44
시가총액:
$333.81M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-20.19
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
+17.95%
1개월 성능:
+6.25%
6개월 성능:
+3.34%
1년 성능:
+142.68%
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CLPT
Clearpoint Neuro Inc
|
13.93 | 333.81M | 30.43M | -18.15M | -9.08M | -0.69 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-25 | 재개 | B. Riley Securities | Buy |
2023-10-24 | 개시 | Stifel | Buy |
2023-02-16 | 재개 | B. Riley Securities | Buy |
2022-04-05 | 재개 | B. Riley Securities | Buy |
2021-03-18 | 개시 | Lake Street | Buy |
2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint - Yahoo Finance
Ameriprise Financial Inc. Has $635,000 Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnersh - GuruFocus
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnership | CLPT Stock News - GuruFocus
Northern Trust Corp Reduces Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Millennium Management LLC Acquires 13,866 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro Inc (CLPT) Trading Down 3.83% on May 28 - GuruFocus
Where are the Opportunities in (CLPT) - news.stocktradersdaily.com
ClearPoint Neuro Approves Key Proposals at Annual Meeting - TipRanks
ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Potential 138% Upside in the Medical Device Sector - DirectorsTalk Interviews
ClearPoint Neuro Updates Director Compensation Plan - TipRanks
Oberland Capital’s Investment in ClearPoint Neuro - Global Legal Chronicle
ClearPoint Neuro targets 15–20 new site activations in 2025 while advancing cell and gene therapy initiatives - MSN
Q2 Earnings Estimate for ClearPoint Neuro Issued By B. Riley - Defense World
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
ClearPoint Neuro’s Earnings Call: Growth Amid Challenges - TipRanks
(CLPT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Call Transcript - Insider Monkey
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro (CLPT) Confirms Fiscal Year 2025 Revenue Foreca - GuruFocus
ClearPoint Neuro Reports Record Q1 2025 Revenue - TipRanks
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo Finance
ClearPoint Neuro (CLPT) Reports Strong Q1 Growth and Strategic A - GuruFocus
Clearpoint Neuro earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Start to FY25 with Record Revenue | CLPT Stock News - GuruFocus
Clearpoint Neuro Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ClearPoint Neuro Reports First Quarter 2025 Results | CLPT Stock News - GuruFocus
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast - Investing.com Australia
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance - Benzinga
CLEARPOINT NEURO Earnings Results: $CLPT Reports Quarterly Earnings - Nasdaq
ClearPoint Neuro Inc (CLPT) Reports Q1 Revenue of $8.5M, Exceedi - GuruFocus
ClearPoint Neuro Reports First Quarter 2025 Results - ACCESS Newswire
ClearPoint Neuro Breaks Revenue Records as Brain Navigation Technology Sales Soar 104% in Q1 2025 - Stock Titan
ClearPoint Neuro Reports Record Q1 2025 Revenue Growth - TipRanks
Clearpoint Neuro Inc QTRLY Loss Per Share $0.22 - marketscreener.com
ClearPoint Neuro Announces Investment of up to $110 Million by O - GuruFocus
Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade - Nasdaq
ClearPoint Neuro (CLPT) Confirms Fiscal Year 2025 Revenue Forecast | CLPT Stock News - GuruFocus
ClearPoint Neuro secures up to $105 million financing By Investing.com - Investing.com Nigeria
ClearPoint Neuro Secures $110 Million Investment Deal - TipRanks
ClearPoint Neuro secures up to $105 million financing - Investing.com
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing | CLPT Stock News - GuruFocus
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing - ACCESS Newswire
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: Wha - GuruFocus
Tower Research Capital LLC TRC Takes $93,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - The AM Reporter
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Bought by Barclays PLC - Defense World
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):